169 related articles for article (PubMed ID: 6120233)
1. beta-Adrenergic blocking agents. alpha- and gamma-methyl(aryloxy)propanolamines.
Lemke TL; Cramer MB; Adamski SW; Pedone CA; Brooker G
J Med Chem; 1981 Oct; 24(10):1211-4. PubMed ID: 6120233
[TBL] [Abstract][Full Text] [Related]
2. Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.
Hoefle ML; Hastings SG; Meyer RF; Corey RM; Holmes A; Stratton CD
J Med Chem; 1975 Feb; 18(2):148-52. PubMed ID: 235644
[TBL] [Abstract][Full Text] [Related]
3. Cardioselectivity of beta-adrenoceptor blocking agents 1. 1-[(4-Hydroxyphenethyl)amino]-3-(aryloxy)propan-2-ols.
Rzeszotarski WJ; Gibson RE; Eckelman WC; Reba RC
J Med Chem; 1979 Jun; 22(6):735-7. PubMed ID: 37339
[TBL] [Abstract][Full Text] [Related]
4. beta 1-selective adrenoceptor antagonists. 1. Synthesis and beta-adrenergic blocking activity of a series of binary (aryloxy)propanolamines.
Kierstead RW; Faraone A; Mennona F; Mullin J; Guthrie RW; Crowley H; Simko B; Blaber LC
J Med Chem; 1983 Nov; 26(11):1561-9. PubMed ID: 6138434
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and beta-adrenergic antagonist activity of novel (3-oxazolinyl-1,4-dihydropyridyl) propanolamines.
Vo D; Wolowyk MW; Knaus EE
Drug Des Discov; 1992 Jul; 8(4):265-72. PubMed ID: 1359908
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and beta-adrenergic antagonist activity of novel (3-cyanodihydropyridyl)propanolamines.
Vo D; Wolowyk MW; Knaus EE
Drug Des Discov; 1991 Dec; 8(2):157-64. PubMed ID: 1686561
[TBL] [Abstract][Full Text] [Related]
7. Ultra-short-acting beta-adrenergic receptor blocking agents. 2. (Aryloxy)propanolamines containing esters on the aryl function.
Erhardt PW; Woo CM; Anderson WG; Gorczynski RJ
J Med Chem; 1982 Dec; 25(12):1408-12. PubMed ID: 6130154
[TBL] [Abstract][Full Text] [Related]
8. Ultra-short-acting beta-adrenergic receptor blocking agents. 1. (Aryloxy)propanolamines containing esters in the nitrogen substituent.
Erhardt PW; Woo CM; Gorczynski RJ; Anderson WG
J Med Chem; 1982 Dec; 25(12):1402-7. PubMed ID: 6130153
[TBL] [Abstract][Full Text] [Related]
9. [(Arylcarbonyl)oxy]propanolamines. 1. Novel beta-blockers with ultrashort duration of action.
Kam ST; Matier WL; Mai KX; Barcelon-Yang C; Borgman RJ; O'Donnell JP; Stampfli HF; Sum CY; Anderson WG; Gorczynski RJ
J Med Chem; 1984 Aug; 27(8):1007-16. PubMed ID: 6146718
[TBL] [Abstract][Full Text] [Related]
10. Role of the (acyloxy)methyl moiety in eliciting the adrenergic beta-blocking activity of 3-(acyloxy)propanolamines.
Macchia B; Balsamo A; Lapucci A; Macchia F; Martinelli A; Ammon HL; Prasad SM; Breschi MC; Ducci M; Martinotti E
J Med Chem; 1987 Apr; 30(4):616-22. PubMed ID: 2882026
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the binding constant (KD) of 125I-labelled 3-(4-iodophenoxy)-1-isopropylamino-propan-2-ol obtained on beta-adrenoceptors in guinea-pig myocardial membranes, with its dissociation constants (KB) obtained on guinea-pig isolated atria and trachea.
O'Donnell SR; Woodcock EA
J Pharm Pharmacol; 1978 Feb; 30(2):96-100. PubMed ID: 24112
[TBL] [Abstract][Full Text] [Related]
12. o-Chlorobenzenesulfonamidic derivatives of (aryloxy)propanolamines as beta-blocking/diuretic agents.
Cecchetti V; Fravolini A; Schiaffella F; Tabarrini O; Bruni G; Segre G
J Med Chem; 1993 Jan; 36(1):157-61. PubMed ID: 8093626
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenoceptor studies. 1. In vitro beta-adrenergic blocking, antiarrhythmic, and local anesthetic activities of a new series of aromatic bis(2-hydroxy-3-isopropylaminopropyl) ethers.
Zaagsma J; Nauta WT
J Med Chem; 1974 May; 17(5):507-13. PubMed ID: 4151492
[No Abstract] [Full Text] [Related]
14. A new series of tricyclic (aryloximino)propanolamines displaying very high selective beta 2-blocking properties.
Jamart-Gregoire B; Caubere P; Blanc M; Gnassounou JP; Advenier C
J Med Chem; 1989 Feb; 32(2):315-20. PubMed ID: 2563296
[TBL] [Abstract][Full Text] [Related]
15. Comparison of interactions of R(+)- and S(-)-isomers of beta-adrenergic partial agonists, befunolol and carteolol, with high affinity site of beta-adrenoceptors in the microsomal fractions from guinea-pig ciliary body, right atria and trachea.
Koike K; Horinouchi T; Takayanagi I
Gen Pharmacol; 1994 Nov; 25(7):1477-81. PubMed ID: 7896063
[TBL] [Abstract][Full Text] [Related]
16. Ultra-short-acting beta-adrenergic receptor blocking agents. 3. Ethylenediamine derivatives of (aryloxy)propanolamines having esters on the aryl function.
Erhardt PW; Woo CM; Matier WL; Gorczynski RJ; Anderson WG
J Med Chem; 1983 Aug; 26(8):1109-12. PubMed ID: 6135805
[TBL] [Abstract][Full Text] [Related]
17. Nondepressant beta-adrenergic blocking agents. 1. Substituted 3-amino-1-(5,6,7,8-tetrahydro-1-naphthoxy)-2-propanols.
Condon ME; Cimarusti CM; Fox R; Narayanan VL; Reid J; Sundeen JE; Hauck FP
J Med Chem; 1978 Sep; 21(9):913-22. PubMed ID: 31485
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and irreversible beta-adrenergic blockade with a bromoacetamido derivative of betaxolol.
Amlaiky N; Leclerc G
J Pharm Sci; 1985 Oct; 74(10):1117-9. PubMed ID: 2867200
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of a novel series of (aryloxy)propanolamines: new selective beta 2-blocking agents.
Carre MC; Youlassani A; Caubere P; Saint-Aubin-Floch A; Blanc M; Advenier C
J Med Chem; 1984 Jun; 27(6):792-9. PubMed ID: 6145801
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cardioselective beta-adrenergic antagonist activity of quinolyloxypropanolamines.
Vo D; Wolowyk MW; Knaus EE
Drug Des Discov; 1992; 9(1):69-78. PubMed ID: 1360842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
